New York, NY (PRWEB) June 07, 2013
Bernstein Liebhard LLP notes the recent launch of a study sponsored by Boston Scientific Corp. that will investigate whether its latest transvaginal mesh device is more beneficial in treating women with pelvic organ prolapse than traditional surgery, and is successful in avoiding complications alleged in mesh lawsuit claims.
As part of the study, for which the company teamed up with the Pelvic Floor Disorders Network, researchers will evaluate patients who received its Uphold LITE transvaginal mesh implant every 6 months to gauge information on patient safety, surgical success, cost-effectiveness, body image and overall quality of life for up to 5 years, according to a report published June 3rd on Boston Scientific's website. The article stated that the company expects to have results for this study by 2017.*
Lawsuits filed over Boston Scientific products not including the Uphold LITE transvaginal mesh implant have alleged mesh erosion, pain, scarring, infection and other complications. Court documents indicate that many of the suits alleging these injuries are now pending in the multidistrict litigation currently underway in the U.S. District Court, Southern District of West Virginia. (In re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2326”))
"We continue to hear from women who allegedly suffered complications stemming from transvaginal mesh complications. Considering the recent controversy surrounding these products, the findings of this research will be of great interest to our Firm,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is actively filing lawsuits on behalf of women allegedly injured by transvaginal mesh implants.
Transvaginal Mesh Lawsuits
Concern about transvaginal mesh has been on the rise since the U.S. Food and Drug Administration (FDA) issued a public health alert in October 2008 that revealed it had received over 1,000 adverse event reports citing pain, mesh erosion, infection and other injuries stemming from this class of devices over a 3-year period. In July 2011, the agency warned of a five-fold increase in the number of reports it had received since 2008, and re-classified the frequency of vaginal mesh complications to occur as “not rare.”**
In addition to the mounting number of transvaginal mesh lawsuits alleging injuries from products manufactured by Boston Scientific, thousands of claims have been filed over products marketed by American Medical Systems, C.R. Bard and Johnson & Johnson’s Ethicon unit.
Many of these claims have been consolidated in the U.S. District Court, Southern District of West Virginia in separate federal multidistrict litigations including: In Re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2325”); In re: C.R. Bard, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2187”); and In re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2327”). Mr. Grand is serving on the Plaintiffs’ Steering Committees for all of these federal proceedings.
At the state court level, numerous claims over products manufactured by C.R. Bard Inc. have been filed in a consolidated litigation underway in Atlantic County Superior Court (In re: Pelvic Mesh Litigation/Bard, No. L-6339-10). Court documents indicate the first trial in this proceeding will begin in September 2013. Additionally, more than 2,800 Ethicon mesh lawsuits were pending in a separate litigation underway in Atlantic County Superior Court in New Jersey as of May 2013 (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10).
Women who received transvaginal mesh implants and are now experiencing complications may be eligible to seek compensation for any additional medical expenses, lost wages, pain and suffering and other damages caused by their injuries. Information about lawsuits alleging mesh implant complications can be found on Bernstein Liebhard's website. Please call a transvaginal mesh lawyer at the Firm directly for a free and confidential case evaluation at 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
Read the full story at http://www.prweb.com/releases/mesh-lawsuit/transvaginal-mesh-lawyer/prweb10813129.htm.
Copyright©2012 Vocus, Inc.
All rights reserved